Arthur Przybyl, President & CEO, Director at ANI Pharmaceuticals, holds 190.31K shares in ANI Pharmaceuticals (Ticker: ANIP), holds 239.82K shares in Akorn (Ticker: AKRXQ).

See the Hottest Stocks Based on Insider Trading >

Arthur Przybyl
ANI Pharmaceuticals (ANIP)
President & CEO, Director

Ranked #4,019 out of 98,624 Corporate Insiders

Profitable Transactions

7 out of 10 Profitable Transactions

Average Return

+36.30%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

ANIP

A breakdown of Arthur Przybyl's holdings

See the Top Stocks by Insiders

Insider Roles

ANI Pharmaceuticals
(ANIP)

President & CEO, Director

Roles that Arthur Przybyl holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

ANI Pharmaceuticals
(ANIP)

Rating:Informative Buy

Date:Sep 09, 2014 - Sep 09, 2015

Return:+139.80%

The most profitable trade made by Arthur Przybyl

See the Latest Stocks Traded by Insiders

Arthur Przybyl's Trading History

ANIP

ANI Pharmaceuticals

Apr 08, 2020

President & CEO, Director

Uninformative Sell

234.76K

$12.80M

AKRXQ

Akorn

Jan 02, 2009

―

Informative Sell

1.47M

$6.48K

List of latest transactions for each holding click on a transaction to see Arthur Przybyl's performance on stock

See All Insider Trading from Today

Arthur Przybyl insider profile FAQ

What is the percentage of profitable transactions made by Arthur Przybyl?

The percentage of profitable transactions made by Arthur Przybyl is 70%.

What is the average return per transaction made by Arthur Przybyl?

The average return per transaction made by Arthur Przybyl is 36.30%.

What stocks does Arthur Przybyl hold?

Arthur Przybyl holds: ANIP, AKRXQ stocks.

What was Arthur Przybyl’s latest transaction?

Arthur Przybyl latest transaction was an Uninformative Sell of $234.76K.

What was Arthur Przybyl's most profitable transaction?

Arthur Przybyl’s most profitable transaction was an Informative Buy of ANIP stock on September 9, 2014. The return on the trade was 139.80%.

What is Arthur Przybyl's role in ANI Pharmaceuticals?

Arthur Przybyl's role in ANI Pharmaceuticals is President & CEO, Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Arthur Przybyl Insider Profile

Arthur Przybyl ANI Pharmaceuticals (ANIP)President & CEO, Director